as on March 4, 2026 at 6:06 am IST
Day's Low
Day's High
6.92%
Downside
0.96%
Upside
52 Week's Low
52 Week's High
100.00%
Downside
-100.00%
Upside
Check Definium Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.7B
EPS (TTM)
-1.906
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-64.06%
Compare market cap, revenue, PE, and other key metrics of Definium Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $1.7B | NA | NA | 0.00% | |
| BUY | $126.2B | 133.18% | 32.47 | 32.94% | |
| BUY | $44.2B | 125.24% | 142.88 | 8.45% | |
| NA | $35.1B | NA | 621.55 | 5.37% | |
| BUY | $82.6B | 77.02% | 18.83 | 31.41% |
Search interest for Definium Therapeutics Inc Stock has decreased by -75% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 months, DFTX stock has moved up by 43.9%
Best in 3 Years
![]()
In the last 3 years, DFTX has outperformed top 5 stocks with highest market-cap in its industry
Best in 1 Year
![]()
In the last 1 year, DFTX has outperformed top 5 stocks with highest market-cap in its industry
| Organisation | Definium Therapeutics Inc |
| Headquarters | One World Trade Center, New York, NY, United States, 10007 |
| CEO | Mr. Robert Barrow |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Mark R. Sullivan J.D. | Chief Legal Officer & Corporate Secretary |
Ms. Brandi L. Roberts CPA, M.B.A. | Chief Financial Officer |
Mr. Peter Mack | Senior Vice President of Pharmaceutical Development & Operations |
Ms. Gitanjali Jain Ogawa | VP & Head of Investor Relations |
Ms. Stephanie Fagan M.S. | Chief Corporate Affairs Officer |
Mr. Robert Barrow | CEO & Director |
Dr. Daniel Rollings Karlin M.A., M.D. | Chief Medical Officer |
Dr. Scott M. Freeman M.D. | Co-Founder & Clinical Advisor |
Mr. Leonard Latchman | Co-Founder |
Ms. Beth Calitri | Vice President of Corporate Communications |
Definium Therapeutics Inc share price today is $17.78 as on . Definium Therapeutics Inc share today touched a day high of $17.95 and a low of $16.55.
Definium Therapeutics Inc share touched a 52 week high of $ on and a 52 week low of $ on . Definium Therapeutics Inc stock price today i.e. is trending at $17.78,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.
Definium Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Definium Therapeutics Inc (DFTX) shares with as little as ₹92.074 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹920.74 in Definium Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Definium Therapeutics Inc share’s latest price of $17.78 as on March 4, 2026 at 12:36 am IST, you will get 0.5624 shares of Definium Therapeutics Inc. Learn more about
fractional shares .